Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease.
about
Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington’s Disease.Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017).Impaired Performance of the Q175 Mouse Model of Huntington's Disease in the Touch Screen Paired Associates Learning Task
P2860
Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Possible use of a H3R antagoni ...... model of Huntington's disease.
@en
Possible use of a H3R antagoni ...... model of Huntington's disease.
@nl
type
label
Possible use of a H3R antagoni ...... model of Huntington's disease.
@en
Possible use of a H3R antagoni ...... model of Huntington's disease.
@nl
prefLabel
Possible use of a H3R antagoni ...... model of Huntington's disease.
@en
Possible use of a H3R antagoni ...... model of Huntington's disease.
@nl
P2860
P50
P356
P1476
Possible use of a H3R antagoni ...... model of Huntington's disease.
@en
P2093
Dawn H Loh
Roger Cachope
P2860
P356
10.1002/PRP2.344
P577
2017-10-01T00:00:00Z